tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Income Statement

Compare
99 Followers

Ikena Oncology Income Statement

Last quarter (Q3 2024), Ikena Oncology's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Ikena Oncology's net income was $-10.23M. See Ikena Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.16M$ 15.62M$ 30.98M$ 9.19M$ 13.75M
Gross Profit
$ 8.14M$ 13.58M$ -16.12M$ -35.65M$ -11.19M
Operating Expenses
$ 84.58M$ 86.52M$ 65.12M$ 53.71M$ 32.24M
Depreciation and Amortization
$ 1.02M$ 2.03M$ 1.72M$ 1.26M$ 122.00K
EBITDA
$ -74.40M$ -70.15M$ -33.59M$ -44.22M$ -18.25M
Operating Income
$ -75.42M$ -70.90M$ -34.14M$ -44.52M$ -18.49M
Other Income/Expenses
$ 7.09M$ 2.14M$ 23.00K$ 263.00K$ 1.68M
Pretax Income
$ -68.33M$ -68.77M$ -34.12M$ -44.26M$ -16.82M
Net Income
$ -68.17M$ -66.63M$ -34.12M$ -44.26M$ -16.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.63$ -1.84$ -0.95$ -1.23$ -0.47
Diluted EPS
$ -1.63$ -1.84$ -0.95$ -1.23$ -0.47
Weighted Average Shares Outstanding
41.74M 36.19M 35.98M 35.85M 35.85M
Weighted Average Shares Outstanding (Diluted)
41.74M 36.19M 35.98M 35.85M 35.85M
Currency in USD

Ikena Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis